Orbital Lymphoproliferative Disorders (OLPDs): Value of MR Imaging for Differentiating Orbital Lymphoma from Benign OPLDs

REFERENCES

1. 1.↵
   2. Goto H

   . Review of Ocular Tumor in Practical Ophthalmology. Vol. 24. Tokyo, Japan: Bunkodo; 2008:5–7
2. 2.↵
   2. Valvassori GE,
   3. Sabnis SS,
   4. Mafee RF, et al

   . Imaging of orbital lymphoproliferative disorders. Radiol Clin North Am 1999;37:135–50

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Jenkins C,
   3. Rose G,
   4. Bunce C, et al

   . Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 2000;84:907–13

   Abstract/FREE Full Text
4. 4.↵
   2. Espinoza GM

   . Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep 2010;12:443–47

   CrossRefPubMed
5. 5.↵
   2. Takahira M,
   3. Ozawa Y,
   4. Kawano M, et al

   . Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders. Int J Rheumatol 2012;2012:635473

   PubMed
6. 6.↵
   2. Garner A

   . Orbital lymphoproliferative disorders. Br J Ophthalmol 1992;76:47–48

   FREE Full Text
7. 7.↵
   2. Priego G,
   3. Majos C,
   4. Climent F, et al

   . Orbital lymphoma: imaging features and differential diagnosis. Insights Imaging 2012;3:337–44

   CrossRefPubMed
8. 8.↵
   2. Akansel G,
   3. Hendrix L,
   4. Erickson BA, et al

   . MRI patterns in orbital malignant lymphoma and atypical lymphocytic infiltrates. Eur J Radiol 2005;53:175–81

   CrossRefPubMed
9. 9.↵
   2. Kapur R,
   3. Sepahdari AR,
   4. Mafee MF, et al

   . MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol 2009;30:64–70

   Abstract/FREE Full Text
10. 10.↵
    2. Sepahdari AR,
    3. Aakalu VK,
    4. Setabutr P, et al

    . Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy. Radiology 2010;256:554–64

    CrossRefPubMed
11. 11.↵
    2. Politi LS,
    3. Forghani R,
    4. Godi C, et al

    . Ocular adnexal lymphoma: diffusion-weighted MR imaging for differential diagnosis and therapeutic monitoring. Radiology 2010;256:565–74

    CrossRefPubMed
12. 12.↵
    2. Roshdy N,
    3. Shahin M,
    4. Kishk H, et al

    . MRI in diagnosis of orbital masses. Curr Eye Res 2010;35:986–91

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Razek AA,
    3. Elkhamary S,
    4. Mousa A

    . Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 2011;53:517–22

    CrossRefPubMed
14. 14.↵
    2. Sepahdari AR,
    3. Kapur R,
    4. Aakalu VK, et al

    . Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study. AJNR Am J Neuroradiol 2012;33:314–19

    Abstract/FREE Full Text
15. 15.↵
    2. Sepahdari AR,
    3. Politi LS,
    4. Aakalu VK, et al

    . Diffusion-weighted imaging of orbital masses: multi-institutional data support a 2-ADC threshold model to categorize lesions as benign, malignant, or indeterminate. AJNR Am J Neuroradiol 2014;35:170–75

    Abstract/FREE Full Text
16. 16.↵
    2. Bhattacharyya N

    . The role of CT and MRI in the diagnosis of chronic rhinosinusitis. Curr Allergy Asthma Rep 2010;10:171–74

    CrossRefPubMed
17. 17.↵
    2. Lee KC,
    3. Moon WK,
    4. Chung JW, et al

    . Assessment of lymph node metastases by contrast-enhanced MR imaging in a head and neck cancer model. Korean J Radiol 2007;8:9–14

    CrossRefPubMed
18. 18.↵
    World Health Organization. Classification of Tumors of Heamatopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008
19. 19.↵
    2. Guo AC,
    3. Cummings TJ,
    4. Dash RC, et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Wu X,
    3. Pertovaara H,
    4. Dastidar P, et al

    . ADC measurements in diffuse large B-cell lymphoma and follicular lymphoma: a DWI and cellularity study. Eur J Radiol 2013;82:e158–64

    CrossRefPubMed
21. 21.↵
    2. Kwee TC,
    3. Takahara T,
    4. Luijten PR, et al

    . ADC measurements of lymph nodes: inter- and intra-observer reproducibility study and an overview of the literature. Eur J Radiol 2010;75:215–20

    CrossRefPubMed
22. 22.↵
    2. Go H,
    3. Kim JE,
    4. Kim YA, et al

    . Ocular adnexal IgG4-related disease: comparative analysis with mucosa-associated lymphoid tissue lymphoma and other chronic inflammatory conditions. Histopathology 2012;60:296–312

    CrossRefPubMed
23. 23.↵
    2. Asai S,
    3. Okami K,
    4. Nakamura N, et al

    . Sonographic appearance of the submandibular glands in patients with immunoglobulin G4-related disease. J Ultrasound Med 2012;31:489–93

    Abstract/FREE Full Text
24. 24.↵
    2. Moteki H,
    3. Yasuo M,
    4. Hamano H, et al

    . IgG4-related chronic rhinosinusitis: a new clinical entity of nasal disease. Acta Otolaryngol 2011;131:518–26

    CrossRefPubMed
25. 25.↵
    2. Hiwatashi A,
    3. Yoshiura T,
    4. Togao O, et al

    . Diffusivity of intraorbital lymphoma vs. IgG4-related disease: 3D turbo field echo with diffusion-sensitised driven-equilibrium preparation technique. Eur Radiol 2014;24:581–86

    CrossRefPubMed